What Is Butalbital 50 mg?

Butalbital 50 mg is a standard strength of the barbiturate component found in combination analgesic products used for tension (or muscle contraction) headaches. Butalbital is an intermediate-acting barbiturate that works by depressing central nervous system activity, helping to relax muscle tension and reduce headache intensity .

Butalbital is rarely prescribed alone. It is almost always combined with other active ingredients, most commonly acetaminophen (300 mg or 325 mg) and sometimes caffeine (40 mg), or with aspirin and codeine . The 50 mg butalbital strength is the most common in these fixed-dose combination products.

Controlled substance status: Butalbital is a Schedule III nonnarcotic controlled substance under federal law. In at least one state (Indiana), butalbital-containing products have been explicitly classified as Schedule III substances requiring controlled substance handling and dispensing rules .

What Butalbital 50 mg Is Prescribed For

Butalbital combination products are indicated for one primary condition:

• Tension (or muscle contraction) headache: For the relief of the symptom complex of tension headache .

Important limitation: Evidence supporting the efficacy and safety of butalbital combination products in the treatment of multiple recurrent headaches is unavailable. Caution is required because butalbital is habit-forming and potentially abusable .

Not for children under 12: Safety and effectiveness in pediatric patients below the age of 12 have not been established .

Active Ingredients

Butalbital 50 mg is typically found in the following combination formulations:

Dosage Guidelines

Usual Adult Dosage: 1 or 2 tablets or capsules every 4 hours as needed for headache. The total daily dose should not exceed 6 tablets/capsules .

Acetaminophen limit: Do not exceed 4,000 mg of acetaminophen per day from all sources. Taking more than this amount can cause serious liver damage .

Renal impairment: For CrCl 10–50 mL/min, give usual dose every 6 hours. For CrCl <10 mL/min, give usual dose every 8 hours .

Hepatic impairment: Consider decreasing the usual dose .

Elderly patients: Dose selection should be cautious, usually starting at the low end of the dosing range, reflecting decreased hepatic, renal, or cardiac function .

Important Safety Information

Habit-Forming Potential: Butalbital may be habit-forming. Tolerance, psychological dependence, and physical dependence may occur, especially following prolonged use of high doses. The average daily dose for barbiturate addicts is usually about 1,500 mg. As tolerance develops, the margin between an intoxication dosage and a fatal dosage becomes smaller. The lethal dose is far less if alcohol is also ingested .

Withdrawal Syndrome: Major withdrawal symptoms (convulsions and delirium) may occur within 16 hours and last up to 5 days after abrupt cessation. Intensity of withdrawal symptoms gradually declines over approximately 15 days .

Do not abruptly discontinue in patients who may be physically dependent. Rapid discontinuation can result in serious withdrawal symptoms, uncontrolled pain, and suicide .

Common Side Effects

The most frequently reported adverse reactions include :

• Drowsiness

• Lightheadedness

• Dizziness

• Sedation

• Shortness of breath

• Nausea

• Vomiting

• Abdominal pain

• Intoxicated feeling

Infrequent side effects: Headache, shaky feeling, tingling, agitation, fainting, fatigue, heavy eyelids, high energy, hot spells, numbness, sluggishness, seizure, mental confusion, excitement, or depression (particularly in elderly or debilitated patients) .

Important Warnings

Acetaminophen Hepatotoxicity: Acetaminophen has been associated with cases of acute liver failure, at times resulting in liver transplant and death. Most cases involve doses exceeding 4,000 mg per day and often involve more than one acetaminophen-containing product. The risk is higher in individuals with underlying liver disease and those who ingest alcohol while taking acetaminophen .

CNS Depression: Alcohol and other CNS depressants may produce additive CNS depression when taken with butalbital combinations. Avoid alcohol and check with a doctor before taking other CNS depressants (antihistamines, sedatives, tranquilizers, other pain medicines, muscle relaxants, anesthetics) .

Impaired Mental/Physical Abilities: This product may impair mental and/or physical abilities required for potentially hazardous tasks such as driving a car or operating machinery. Avoid such tasks while taking this medication .

Serious Skin Reactions: This medicine may cause serious skin reactions (e.g., acute generalized exanthematous pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis). Seek medical attention right away for blistering, peeling, or loosening of the skin .

Anaphylaxis: Serious allergic reactions, including anaphylaxis, can be life-threatening. Seek immediate medical attention for chest tightness, trouble breathing, or swelling of the face, lips, or tongue .

Medication Overuse Headache: Use of butalbital as infrequently as 5 days per month has been linked to transformation into chronic daily headache and medication overuse headache. Use should preferably be limited to no more than two to three treatment days per week .

Drug Interactions

MAO Inhibitors: The CNS effects of butalbital may be enhanced by monoamine oxidase (MAO) inhibitors .

CNS Depressants: Butalbital, acetaminophen, and caffeine may enhance the effects of other narcotic analgesics, alcohol, general anesthetics, tranquilizers, sedative-hypnotics, or other CNS depressants, causing increased CNS depression .

Codeine-containing formulations: Use of CYP3A4 inducers, 3A4 inhibitors, or 2D6 inhibitors requires careful consideration due to effects on codeine metabolism to morphine .

Who Should Not Take Butalbital 50 mg

Butalbital combination products are contraindicated in patients with :

• Hypersensitivity or intolerance to acetaminophen, caffeine, butalbital, or codeine

• Porphyria (enzyme problem)

• Children younger than 12 years (for codeine-containing formulations)

• Post-operative management in children younger than 18 following tonsillectomy and/or adenoidectomy (for codeine-containing formulations)

• Significant respiratory depression (for codeine-containing formulations)

• Acute or severe bronchial asthma (for codeine-containing formulations)

• Concurrent use of MAOIs or use within the last 14 days (for codeine-containing formulations)

How Prescriptions Work

As a controlled substance (Schedule III in some states and federally for codeine-containing formulations), butalbital combination products are subject to regulations:

• Refills: Limited according to state and federal controlled substance laws.

• Regular monitoring: Patients on butalbital require careful monitoring with use preferably limited to no more than two to three treatment days per week .

• Tapering required: Do not abruptly discontinue in patients who may be physically dependent. A gradual withdrawal under medical supervision is required .

• Safe storage: Keep in a safe place out of reach of children. Do not share with others .

Frequently Asked Questions

Is butalbital 50 mg safe for long-term use?

No. Butalbital is habit-forming, and extended use is not recommended. Use of butalbital as infrequently as 5 days per month has been linked to medication overuse headache and transformation into chronic daily headache .

Can I stop taking butalbital 50 mg suddenly?

No. Abrupt discontinuation can cause major withdrawal symptoms including convulsions and delirium within 16 hours. A gradual taper under medical supervision is required .

Can I drink alcohol while taking butalbital 50 mg?

No. Alcohol increases CNS depression and the risk of liver damage from acetaminophen. The lethal dose of barbiturates is far less if alcohol is also ingested .

What happens if I take too much butalbital 50 mg?

Seek emergency help immediately. Signs of overdose include confusion, severe drowsiness, slow or shallow breathing, and loss of consciousness. Do not exceed 4,000 mg of acetaminophen per day .

Does butalbital cause medication overuse headache?

Yes. Butalbital is associated with a high risk of medication overuse headache. If you are having headaches more often than before you started using this medicine, this may indicate dependence .

Is butalbital safe during pregnancy?

There are only limited human data for butalbital during pregnancy. Withdrawal seizures were reported in a two-day-old infant whose mother took a butalbital-containing drug during the last two months of pregnancy. Use only when clearly needed .

What is the difference between butalbital 50 mg and butalbital 25 mg?

The 50 mg strength is the standard dose in most combination products. Some products contain 25 mg butalbital per tablet, requiring more tablets for the same dose .

Conclusion

Butalbital 50 mg is a standard strength barbiturate component in combination analgesics approved for tension headache. As a controlled substance with significant habit-forming potential, it carries risks of tolerance, dependence, and a life-threatening withdrawal syndrome characterized by seizures and delirium. Major withdrawal can occur within 16 hours of abrupt cessation. Common side effects include drowsiness, dizziness, and nausea. Serious risks include acetaminophen-related liver failure, CNS depression when combined with alcohol or other depressants, serious skin reactions, and medication overuse headache with frequent use. Use should be limited to no more than two to three treatment days per week, and discontinuation must be gradual under medical supervision.